Vivek Peddakota

Vivek Peddakota

Auto-generated profile, based on publicly available information

Vivek Peddakota

Department of Hepato-Pancreato-Biliary and Transplant Surgery, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2026 in HPB
Verified
Journal Article
Open access
VPVivek Peddakota
Vivek Peddakota
RORuth Owen
Ruth Owen
NJNejo Joseph
Nejo Joseph
LMLitesh Chouhan Mudavath
Litesh Chouhan Mudavath
CKCecilie Siggaard Knoph
Cecilie Siggaard Knoph
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana
This systematic review aims to identify the core outcome domains and assessment methods currently used in randomised controlled trials (RCTs) for acute postoperative pain following pancreatic surgery. PubMed, Embase, Web of Science, and the Cochrane Library were searched without restrictions. Eligible studies were screened and data extracted for pain assessment tools, analgesic outcomes, adverse effects, pain interference and quality-of-life measures. Fifteen RCTs involving 1034 patients were included. All trials assessed pain intensity using a visual analogue scale (n = 11) or a numerical rating scale (n = 4). Analgesic consumption was reported in 13 trials, with significant variability in the reporting, rescue analgesia and adverse effects. Pain interference or physical function was described in 10 trials, including pain on coughing (n = 4), mobilisation (n = 3), % gait speed and % peak cough flow (n = 2). Multidimensional tools were rarely used, with a single RCT employing three different scales. Psychological function was assessed in one trial using anxiety and depression scales. There was notable heterogeneity in pain domains assessed and the tools used across pain management RCTs post-pancreatectomy. This highlights the need for standardized core outcome domains and multidimensional tools specific to pancreatic surgery to enable comparability of data and robust analysis.

19 March 2026 in Pancreatology
Verified
Journal Article
Open access
KCKurt Carabott
Kurt Carabott
MKMatta Kuzman
Matta Kuzman
STSamuel Tingle
Samuel Tingle
VPVivek Peddakota
Vivek Peddakota
MAMaisam Abu-El-Haija
Maisam Abu-El-Haija
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana
To systematically review the literature on quality of life (QOL) after islet transplantation following total pancreatectomy in chronic pancreatitis (CP). Total pancreatectomy and islet auto-transplantation (TPIAT) aims to relieve pain while preserving β-cell function in CP patients. A systematic search of Medline, PubMed, EMBASE was performed according to PRISMA framework to identify studies reporting on QOL after TPIAT for CP. Random effects meta-analyses were performed to pool results on change in physical component summary (PCS) and mental component summary (MCS) QOL scores. Twenty-nine studies performed between 2011 and 2025 with a total of 4075 patients were included of which 24.8% were paediatric patients. 19 studies used the RAND SF36 QOL instrument, the most used instrument. The QOL surveys were performed from 1 month to more than 10 years post-TPIAT. Response rates varied from 14% to 100%. PCS scores were significantly higher at 1-year post-TPIAT (pooled estimate 10.36, 95% CI 7.33 to 13.4, p = <0.001) and at longest follow up (pooled estimate 16.07, 95% CI 5.80 to 26.34, p = 0.002). MCS scores were also significantly higher at 1-year post-TPIAT (pooled estimate 5.54, 95% CI 3.30 to 7.78, p = <0.001) and at longest follow up (pooled estimate 13.26, 95% CI 3.67 to 22.85, p = 0.007). Improvements in QOL appear to persist beyond 10 years. TPIAT offers both short-term and long-term improvements in physical and mental components of QOL. However, development of TPIAT specific QOL instrument is warranted to capture TPIAT specific outcomes which determine QOL.